IXHL
Price
$0.35
Change
-$0.01 (-2.78%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
124.1M
Intraday Buy/Sell Signals
NBIX
Price
$141.48
Change
-$1.17 (-0.82%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
14.15B
6 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

IXHL vs NBIX

Header iconIXHL vs NBIX Comparison
Open Charts IXHL vs NBIXBanner chart's image
Incannex Healthcare
Price$0.35
Change-$0.01 (-2.78%)
Volume$47.3K
Capitalization124.1M
Neurocrine Biosciences
Price$141.48
Change-$1.17 (-0.82%)
Volume$15.47K
Capitalization14.15B
IXHL vs NBIX Comparison Chart in %
IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IXHL vs. NBIX commentary
Oct 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IXHL is a Hold and NBIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 22, 2025
Stock price -- (IXHL: $0.36 vs. NBIX: $142.65)
Brand notoriety: IXHL and NBIX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IXHL: 20% vs. NBIX: 64%
Market capitalization -- IXHL: $124.1M vs. NBIX: $14.15B
IXHL [@Pharmaceuticals: Generic] is valued at $124.1M. NBIX’s [@Pharmaceuticals: Generic] market capitalization is $14.15B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.74B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IXHL’s FA Score shows that 0 FA rating(s) are green whileNBIX’s FA Score has 1 green FA rating(s).

  • IXHL’s FA Score: 0 green, 5 red.
  • NBIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NBIX is a better buy in the long-term than IXHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IXHL’s TA Score shows that 3 TA indicator(s) are bullish while NBIX’s TA Score has 5 bullish TA indicator(s).

  • IXHL’s TA Score: 3 bullish, 6 bearish.
  • NBIX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NBIX is a better buy in the short-term than IXHL.

Price Growth

IXHL (@Pharmaceuticals: Generic) experienced а -6.33% price change this week, while NBIX (@Pharmaceuticals: Generic) price change was +3.95% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.03%. For the same industry, the average monthly price growth was -0.63%, and the average quarterly price growth was +42.82%.

Reported Earning Dates

NBIX is expected to report earnings on Oct 28, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-2.03% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($14.1B) has a higher market cap than IXHL($124M). NBIX YTD gains are higher at: 4.505 vs. IXHL (-83.165). NBIX has higher annual earnings (EBITDA): 557M vs. IXHL (-21.34M). NBIX has more cash in the bank: 976M vs. IXHL (6.71M). IXHL has less debt than NBIX: IXHL (1.69M) vs NBIX (439M). NBIX has higher revenues than IXHL: NBIX (2.51B) vs IXHL (98K).
IXHLNBIXIXHL / NBIX
Capitalization124M14.1B1%
EBITDA-21.34M557M-4%
Gain YTD-83.1654.505-1,846%
P/E RatioN/A42.20-
Revenue98K2.51B0%
Total Cash6.71M976M1%
Total Debt1.69M439M0%
FUNDAMENTALS RATINGS
NBIX: Fundamental Ratings
NBIX
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
58
SMR RATING
1..100
59
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IXHLNBIX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
55%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 20 days ago
79%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 13 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ODOT3.920.08
+2.01%
Osprey Polkadot Trust
LCTU73.380.09
+0.12%
BlackRock US Carbon Transition Rdnss ETF
OIA5.99N/A
+0.08%
INVESCO Municipal Income OPPORTUNITIES TRUST
AGNG34.21-0.19
-0.55%
Global X Aging Population ETF
ION39.34-0.91
-2.25%
ProShares S&P Global Cor Btty Mtls ETF

IXHL and

Correlation & Price change

A.I.dvisor tells us that IXHL and INM have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IXHL and INM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IXHL
1D Price
Change %
IXHL100%
-6.08%
INM - IXHL
24%
Poorly correlated
+0.47%
ESPR - IXHL
23%
Poorly correlated
-1.06%
NBIX - IXHL
22%
Poorly correlated
+0.93%
HROW - IXHL
22%
Poorly correlated
-3.11%
YCBD - IXHL
20%
Poorly correlated
-7.83%
More